Helius Medical Technologies Inc HSDT

Healthcare Medical Devices

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

NDAQ:HSDT - Post by User

Helius Medical Technologies Inc

Bullboard Posts

Comment by Mcburnzon Nov 09, 2017 9:02pm

106 Views

Post# 26936859

RE:RE:RE:RE:RE:RE:RE:RE:RE:Failed to meet primary endpoint

Well we are assuming the patients that received the small amount of frequency had been through all other physio therapy and this was ther last result. There was a high requirement for recruits, this was supose to be a last result for them. So its highly unlikely that physio now alone gave them improvements. Phil has told fabrice he has been working with the fda all along and is confident. I'm sure they were aware this was a possible outcome they can't be that stupid. There does need to be a further news release imo to clarify the results and expectations if ther is this much confusion on a stockhouse board I'm.sure every investor is asking the same questions.

Bullboard Posts

Cybin launches new program phase to treat Major Depressive Disorder